McKinsey & Co. settles OxyContin claims with W.Va.

LEWISBURG, W.Va. — West Virginia Attorney General Patrick Morrisey announced Thursday that a settlement has been reached between the Mountain State and management consulting firm McKinsey and Company.

West Virginia had sued the company in Greenbrier Circuit Court for violating West Virginia’s Consumer Credit and Protection Act by helping Purdue Pharma triple sales of OxyContin, even after Purdue pleaded guilty to misbranding the drug. Morrisey had claimed that McKinsey took advantage of the opioid crisis to increase sales of the drug.

McKinsey will pay West Virginia $10 million to settle the case, but admits no wrongdoing.

The settlement specifies the money will be used “to the extent practicable, to remediate the harms caused to the state and its citizens by the opioid epidemic and to recover the costs incurred by the State in investigating and pursuing these claims.”

Earlier this week, Mingo County and the Town of Kermit filed a similar lawsuit against the company in federal court. That case remains pending.